SEN0014196
A multicentre, multinational prospective observational imaging biomarker study in early stage Huntington’s disease (HD) patients to assess imaging techniques and parameters able to support efficacy studies with SEN0014196 in HD patients during Phase II and III studies
Phase 1/2 study testing an investigational treatment in Huntington's disease.
Recruitment endedPhase I/IINot specifiedISRCTNTreatment trial
Recruiting in: United Kingdom
Sponsor: Siena Biotech (Italy)
Preparing a short plain-English summary.